Ossio closes $22M in equity financings — Raised $35M to date

Written by Shayna Korol | March 11, 2019 | Print  |

Orthopedic fixation company Ossio secured $22 million in financing.

Three things to know:

1. OCV Partners led the equity financings, with continued participation from Ortho Vision and Secocha Ventures, both existing investors.

2. Ossio has raised a total of $35 million to date. The company will use the proceeds for U.S. commercialization of its OSSIOfiber Intelligent Bone Regeneration Technology and operational expansion.

3. The OSSIOfiber technology uses a proprietary bio-integrative material designed to provide stability and maintain the alignment of bone fractures, osteotomies, arthrodesis and bone grafts during the healing process without permanent hardware.

More articles on devices:
21 spine devices receive FDA 510(k) clearance in February
FDA recorded 1.1M medical device-related injuries in internal reporting system — 4 things to know
SpineGuard granted patent for spinal ultrasound mapping technology — 3 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months